Concomitant CXCR4 and CXCR7 expression predicts poor prognosis in renal cancer

Current Cancer Drug Targets

Volumn 10, Issue 7, 2010, Pages 772-781

  D'Alterio, C ^a   Consales, C ^a   Polimeno, M ^a   Franco, R ^a   Cindolo, L ^a   Portella, L ^a   Cioffi, M ^a   Calemma, R ^a   Marra, L ^a   Claudio, L ^a   Perdona S ^a   Pignata, S ^a   Facchini, G ^a   Carteni G ^b   Longo, N ^c   Pucci, L ^c   Ottaiano, A ^d   Costantini, S ^e   Castello, G ^a   Scala, S ^a  

^a Department of Oncological Immunology ^*  (Italy)

^b CARDARELLI HOSPITAL   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e INT CROM   (Italy)

Author keywords

CXCR4; CXCR7; Disease free survival; Molecular target; Prognosis; Renal cell carcinoma

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7;

ADULT; AGED; ARTICLE; CANCER RELAPSE; CANCER SIZE; CANCER STAGING; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 78649256331     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/156800910793605839     Document Type: Article

References (36)

1. Prenen, H.; Gil, T.; Awada, A. New therapeutic developments in renal cell cancer. Crit. Rev. Oncol. Hematol. 2009, 69, 56-63.
2. Cyster, J. G. Chemokines and cell migration in secondary lymphoid organs. Science 1999, 286, 2098-2102.
3. Balkwill, F. The significance of cancer cell expression of the chemokine receptor CXCR4. Semin. Cancer Biol. 2004, 4, 171-179.
4. Youn, B. S.; Mantel, C.; Broxmeyer, H. E. Chemokines, chemokine receptors and hematopoiesis. Immunol. Rev. 2000, 177, 150-174.
5. Lataillade, J. J.; Clay, D.; Dupuy, C.; Rigal, S.; Jasmin, C.; Bourin, P.; Le Bousse-Kerdilès, M. C. Chemokine SDF-1 enhances circulating CD34(+) cell proliferation in synergy with cytokines, possible role in progenitor survival. Blood 2000, 95, 756-768.
6. Müller, A.; Homey, B.; Soto, H.; Ge, N.; Catron, D.; Buchanan, M. E.; McClanahan, T.; Murphy, E.; Yuan, W.; Wagner, S. N.; Barrera, J. L.; Mohar, A.; Verástegui, E.; Zlotnik, A. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410, 50-56.
7. Rempel, S. A.; Dudas, S.; Ge, S.; Gutiérrez, J. A. Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. Clin. Cancer Res. 2000, 6, 102-111.
8. Ottaiano, A.; di Palma, A.; Napolitano, M.; Pisano, C.; Pignata, S.; Tatangelo, F.; Botti, G.; Acquaviva, A. M.; Castello, G.; Ascierto, P. A.; Iaffaioli, R. V.; Scala, S. Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells. Cancer Immunol. Immunother. 2005, 54, 781-791.
9. Scala, S.; Giuliano, P.; Ascierto, P. A.; Ierano, C.; Franco, R.; Napolitano, M.; Ottaiano, A.; Lombardi, M. L.; Luongo M.; Simeone, E.; Castiglia, D.; Mauro, F.; De Michele, I.; Calemma, R.; Botti, G.; Caraco, C.; Nicoletti, G.; Satriano, R. A.; Castello G. Human melanoma metastases express functional CXCR4. Clin. Cancer Res. 2006, 12, 2427-2433.
10. Scala, S.; Ottaiano, A.; Ascierto, P. A.; Cavalli, M.; Simeone, E.; Giuliano, P.; Napolitano, M.; Franco, R.; Botti, G.; Castello, G. Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma. Clin. Cancer Res. 2005, 11, 1835-1841.
11. Staller, P.; Sulitkova, J.; Lisztwan, J.; Moch, H.; Oakeley, E. J.; Krek, W. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature 2003, 425, 307-311.
12. Wehler, T. C.; Graf, C.; Biesterfeld, S.; Brenner, W.; Schadt, J.; Gockel, I.; Berger, M. R.; Thüroff, J. W.; Galle, P. R.; Moehler, M.; Schimanski, C. C. Strong expression of chemokine receptor CXCR4 by renal cell carcinoma correlates with advanced disease. J. Oncol. 2008, 2008, 626340.
13. Burns, J. M.; Summers, B. C.; Wang, Y.; Melikian, A.; Berahovich, R.; Miao, Z.; Penfold, M. E.; Sunshine, M. J.; Littman, D. R.; Kuo, C. J.; Wei, K.; McMaster, B. E.; Wright, K.; Howard, M. C.; Schall, T. J. A novel chemokine receptor for SDF-1and I-Tac involved in cell survival, cell adhesion, and tumor development. J. Exp. Med. 2006, 203, 2201-2213.
14. Thelen, M.; Thelen, S. CXCR7, CXCR4 and CXCL12, an eccentric trio? J. Neuroimmunol. 2008, 198, 9-13.
15. Boldajipour, B.; Mahabaleshwar, H.; Kardash, E.; Reichman-Fried, M.; Blaser, H.; Minina, S.; Wilson, D.; Xu, Q.; Raz, E. Control of chemokine-guided cell migration by ligand sequestration. Cell 2008,132, 463-473.
16. Sierro, F.; Biben, C.; Martínez-Muñoz, L.; Mellado, M.; Ransohoff, R. M.; Li, M.; Woehl, B.; Leung, H.; Groom, J.; Batten, M.; Harvey, R. P.; Martínez-A, C.; Mackay, C. R.; Mackay, F. Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc. Natl. Acad. Sci. USA 2007, 104, 14759-14764.
17. Mazzinghi, B.; Ronconi, E.; Lazzeri, E.; Sagrinati, C.; Ballerini, L.; Angelotti, M. L.; Parente, E.; Mancina, R.; Netti, G. S.; Becherucci, F.; Gacci, M.; Carini, M.; Gesualdo, L.; Rotondi, M.; Maggi, E.; Lasagni, L.; Serio, M.; Romagnani, S.; Romagnani, P. Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells. J. Exp. Med. 2008, 205, 479-490.
18. Miao, Z.; Luker, K. E.; Summers, B. C.; Berahovich, R.; Bhojani, M. S.; Rehemtulla, A.; Kleer, C. G.; Essner, J. J.; Nasevicius, A.; Luker, G. D.; Howard, M. C.; Schall, T. J. CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc. Natl. Acad. Sci. USA 2007, 104, 15735-15740.
19. Wang, J.; Shiozawa, Y.; Wang, J.; Wang, Y.; Jung, Y.; Pienta, K. J.; Mehra, R.; Loberg, R.; Taichman, R. S. The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer. J. Biol. Chem. 2008, 283, 4283-4294.
20. Schutyser, E.; Su, Y.; Yu, Y.; Gouwy, M.; Zaja-Milatovic, S.; Van Damme, J.; Richmond, A. Hypoxia enhances CXCR4 expression in human microvascular endothelial cells and human melanoma cells. Eur. Cytokine Netw. 2007, 18, 59-70.
21. Iwakiri, S.; Mino, N.; Takahashi, T.; Sonore, M.; Nagai, S.; Okubo, K.; Wada, H.; Date, H.; Miyahara, R. Higher expression of chemokine receptor CXCR7 is linked to early and metastatic recurrence in pathological stage I non small cell lung cancer. Cancer 2009,115, 2580-2593.
22. Maréchal, R.; Demetter, P.; Nagy, N.; Berton, A.; Decaestecker, C.; Polus, M.; Closset, J.; Devière, J.; Salmon, I.; Van Laethem, J. L. High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma. Br. J. Cancer 2009, 100, 1444-1451.
23. Kovacs, G.; Akhtar, M.; Beckwith, B. J.; Bugert, P.; Cooper, C. S.; Delahunt, B.; Eble, J. N.; Fleming, S.; Ljungberg, B.; Medeiros, L. J.; Moch, H.; Reuter, V. E.; Ritz, E.; Roos, G.; Schmidt, D.; Srigley, J. R.; Störkel, S.; van den Berg, E.; Zbar, B. The Heidelberg classification of renal cell tumours. J. Pathol. 1997, 183, 131-133.
24. Patard, J. J.; Leray, E.; Cindolo, L.; Ficarra, V.; Rodriguez, A.; De La Taille, A.; Tostain, J.; Artibani, W.; Abbou, C. C.; Guillé, F.; Chopin, D. K.; Lobel, B. Multi-institutional validation of a symptom based classification for renal cell carcinoma. J. Urol. 2004, 172, 858-862.
25. Schmittgen, T. D.; Livak, J. Analyzing real time PCR data by the comparative Ct method. Nat. Protoc. 2008, 3, 1101-1108.
26. Luker, K. E.; Gupta, M.; Steele, J. M.; Foerster, B. R.; Luker, G. D. Imaging ligand-dependent activation of CXCR7. Neoplasia 2009, 10, 1022-1035.
27. Rajagopal, S.; Kim, J.; Ahn, S.; Craig, S.; Lam, C. M.; Gerard, N. P.; Gerard, C.; Lefkowitz, R. J. ß-arrestin but not G proteinmediated signalling by the "decoy" receptor CXCR7 Proc. Natl. Acad. Sci. USA 2010, 107(2), 628-632.
28. Levoye, A.; Balabanian, K.; Baleux, F.; Bachelerie, F.; Lagane, B. CXCR7 heterodimerize with CXCR4 and regulates CXCL12-mediated G protein signalling. Blood 2009, 113, 6085-6093.
29. Mellado, M.; Rodriguez-Frade, J. M.; Vila-Coro, A. J.; Fernandez, S.; Martin de Ana, A.; Jones, D. R.; Toran, J. L.; Martinez, A. C. Chemokine receptor homo-heterodimerization activates distinct signaling pathways. EMBO J. 2001, 20(10), 2497-2507.
30. Percheranchier, R. B.; Berniche, Y. A.; Slight, I.; Volkmer-Engert, R.; Tamamura, H.; Fujii, N.; Bouvier, M.; Heveker, N.; Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo-and heterodimers. J. Biol. Chem. 2005, 280(11), 9895-9903.
31. Maksym, R. B.; Tarnowski, M.; Grymula, K.; Tarnowska, J.; Wysoczynski, M.; Liu, R.; Czerny, B.; Ratajczak, J.; Kucia, M.; Ratajczak, M. Z. The role of stromal-derived factor-1-CXCR7 axis in development and cancer. Eur. J. Pharmacol. 2009, 625(1-3), 31-40.
32. Meijer, J.; Ogink, J.; Roos, E. Effect of the chemokine receptor CXCR7 on proliferation of carcinoma cells in vitro and in vivo. Br. J. Cancer 2008, 99, 1493-1501.
33. Tarnowski, M.; Grymula, K.; Reca, R.; Jankowski, K.; Maksym, R.; Tarnowska, J.; Przybylski, G.; Barr, F. G.; Kucia, M.; Ratajczak, M. Z. Regulation of expression of stromal-derived factor-1 receptors: CXCR4 and CXCR7 in human rhabdomyosarcomas. Mol. Cancer Res. 2010, 8(1), 1-14.
34. Grymula, K.; Tarnowski, M.; Wysoczynski, M.; Drukala, J.; Barr, F. G.; Ratajczak, J.; Kucia, M.; Ratajczak, M. Z. Overlapping and distinct role of CXCR7-SDF-1/ITAC and CXCR4-SDF-1 axes in regulating metastatic behaviour of human rhabdomyosarcomas. Int. J. Cancer 2010, 16, Feb [Epub ahead of print].
35. Burger, J. A.; Peled, A. CXCR4 antagonists, targeting the microenvironment in leukemia and other cancers. Leukemia 2009, 23, 43-52.
36. Hartmann, T. N.; Grabovsky, V.; Pasvolsky, R.; Shulman, Z.; Buss, E. C.; Spiegel, A.; Nagler, A.; Lapidot, T.; Thelen, M.; Alon, R. A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokinetriggered motility of human T lymphocytes and CD34+ cells. J. Leukoc. Biol. 2008, 84, 1130-1140.